METiS Attends 2023 Fortune Global Tech Forum, Sharing Insights on Future Health Trends_News_剂泰科技(北京)股份有限公司

Home News News
METiS Attends 2023 Fortune Global Tech Forum, Sharing Insights on Future Health Trends
2023.04.04

"Humanity has never ceased in its pursuit of technology, and in turn, the advance of science and technology has also pushed the boundaries of business and reshaped our society. Today, we are witnessing an overwhelming emergence of new technologies, including artificial intelligence, quantum computing, chip manufacturing, medical biology, and controllable nuclear fusion, many of which are on their cusp of explosive growth. Meanwhile, amidst the hustle and bustle of scientific and technological progress, we need to understand: What kind of huge changes or impacts will technology bring to human beings? What kind of guidelines do pioneers who master cutting-edge technologies need to adhere to, to ensure that new technologies can promote the continued prosperity and development of mankind?”

On March 30, the 2023 Fortune Global Tech Forum was held in Guangzhou. The Fortune Global Tech Forum is an annual international technology event hosted by Fortune. The event brings together executives from leading global companies, scholars who are at the forefront of technological progress in their respective fields, high-profile technology entrepreneurs, and well-known technology investors to share insights and forecast trends on hot topics such as the computing power economy, ChatGPT, electric vehicles, carbon neutrality, the digital economy, chip manufacturing, healthcare, and artificial intelligence.

The forum's theme is "New Frontiers: Change and Resilience" , which highlights the important trends in the global technology industry. This forum provides a unique opportunity for business executives, entrepreneurs, and investors to engage with the leaders of the digital revolution and discuss how to shape the future world.

Dr.Wenshou Wang, the co-founder and COO of METiS Pharmaceuticals, was honored to represent METiS Pharmaceuticals upon the invitation to attend the Forum, and in the sub-forum titled "the Future of Healthcare," Dr. Wang joined Clay Chandler, the executive editor for Asia at Fortune, Cheryl Cui, the co-founder and CEO of Bota Bio, Shuhao Wen, the co-founder and president of XtalPi Inc., and Huanqing Gu, the founder and president of the Stemcell United Ltd.(SCU), to discuss how innovative technologies can empower and enhance healthcare, and explore the cutting-edge new trends, in the context of the rapid development of science and technology.

Dr. Wang remarked that the development of new drugs is becoming increasingly time-consuming and costly at present. He asserted that AI technology will revolutionize the pharmaceutical industry by automating the drug development process and making it more effective. “Rather than relying on blind trial-and-error methods, AI can provide a more purposeful approach to drug development, reducing the need for trial and error. Additionally, automating the manual tasks will significantly improve research and development efficiency.’’ he further explained.

METiS Attends 2023 Fortune Global Tech Forum, Sharing Insights on Future Health Trends(图1)

METiS Attends 2023 Fortune Global Tech Forum, Sharing Insights on Future Health Trends(图2)

Dr. Wenshou Wang, the co-founder and COO of METiS Pharmaceuticals, sharing his insights at the forum

"AI drug delivery" technology will overcome the technological bottlenecks of conventional drug R&D, and are poised to become the key to developing a new generation of treatment for the future, exemplified RNA therapeutics. The technology refers to the precise delivery of drugs and gene therapies to target organs, tissues and cells to cure diseases. On the other hand, in the development of new small molecule drugs, drug delivery technology can also improve pharmaceutical preparations/formulations of existing drugs, so as to develop new small molecule drugs with lower toxicity and better efficacy in a faster and more efficient manner. METiS is pushing the boundaries of drugs with the world's leading technology platform for targeted drug delivery, which has diverse application potentials and offers excellent market prospects.



About FORTUNE

Fortune is a globally influential business media organization that focuses on reporting on the ever-changing business landscape. It is renowned for its well-respected lists, such as the Fortune Global 500.

Fortune has the unparalleled capability and influence to bring together top business leaders, opinion leaders, policymakers, and experts from various industries. From exclusive dinners to large-scale business and financial conferences, Fortune's events are meticulously planned and executed to ensure the utmost quality. Renowned economists and CEOs of multinational corporations participate in these gatherings to discuss innovative technologies and cutting-edge industries, as well as hot issues related to corporate development. By fostering the consensus and foresight, these events help to expand the influence of the host cities, and enable the participants to work together towards extraordinary achievements. Leveraging its strategic focuses, high-level cross-industry interactions, and insights from a professional editorial team, Fortune offers exciting conferences and innovative activities.